Adamas Pharmaceuticals, Inc. Information Request Form
Company
Adamas Pharmaceuticals, Inc.
Ticker
ADMS
Levi & Korsinsky announces it has commenced an investigation ofAdamas Pharmaceuticals, Inc. (NASDAQ:ADMS) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.